MedTrace Logo

Assessment of Lotrafilcon A Contact Lenses

NCT01185834 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2012-07-10

Study results available
· View outcomes & findings →

Summary

The purpose of this 3-month study is to evaluate subjective responses to an upgraded contact lens.

Conditions

  • Myopia

Interventions

DEVICE

Lotrafilcon A upgrade soft contact lens

Silicone hydrogel contact lens approved for daily wear and extended wear up to 30 consecutive nights.

Sponsors & Collaborators

  • CIBA VISION

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2010-12-31
Completion
2010-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01185834 on ClinicalTrials.gov